Skip to main content
Top
Published in: BMC Immunology 1/2008

Open Access 01-12-2008 | Research article

Evaluation of MHC class I peptide binding prediction servers: Applications for vaccine research

Authors: Hong Huang Lin, Surajit Ray, Songsak Tongchusak, Ellis L Reinherz, Vladimir Brusic

Published in: BMC Immunology | Issue 1/2008

Login to get access

Abstract

Background

Protein antigens and their specific epitopes are formulation targets for epitope-based vaccines. A number of prediction servers are available for identification of peptides that bind major histocompatibility complex class I (MHC-I) molecules. The lack of standardized methodology and large number of human MHC-I molecules make the selection of appropriate prediction servers difficult. This study reports a comparative evaluation of thirty prediction servers for seven human MHC-I molecules.

Results

Of 147 individual predictors 39 have shown excellent, 47 good, 33 marginal, and 28 poor ability to classify binders from non-binders. The classifiers for HLA-A*0201, A*0301, A*1101, B*0702, B*0801, and B*1501 have excellent, and for A*2402 moderate classification accuracy. Sixteen prediction servers predict peptide binding affinity to MHC-I molecules with high accuracy; correlation coefficients ranging from r = 0.55 (B*0801) to r = 0.87 (A*0201).

Conclusion

Non-linear predictors outperform matrix-based predictors. Most predictors can be improved by non-linear transformations of their raw prediction scores. The best predictors of peptide binding are also best in prediction of T-cell epitopes. We propose a new standard for MHC-I binding prediction – a common scale for normalization of prediction scores, applicable to both experimental and predicted data. The results of this study provide assistance to researchers in selection of most adequate prediction tools and selection criteria that suit the needs of their projects.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ehreth J: The value of vaccination: a global perspective. Vaccine. 2003, 21 (27–30): 4105-4117. 10.1016/S0264-410X(03)00377-3.CrossRefPubMed Ehreth J: The value of vaccination: a global perspective. Vaccine. 2003, 21 (27–30): 4105-4117. 10.1016/S0264-410X(03)00377-3.CrossRefPubMed
2.
go back to reference Brusic V, August JT, Petrovsky N: Information technologies for vaccine research. Expert Rev Vaccines. 2005, 4 (3): 407-417. 10.1586/14760584.4.3.407.CrossRefPubMed Brusic V, August JT, Petrovsky N: Information technologies for vaccine research. Expert Rev Vaccines. 2005, 4 (3): 407-417. 10.1586/14760584.4.3.407.CrossRefPubMed
3.
go back to reference Purcell AW, McCluskey J, Rossjohn J: More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov. 2007, 6 (5): 404-414. 10.1038/nrd2224.CrossRefPubMed Purcell AW, McCluskey J, Rossjohn J: More than one reason to rethink the use of peptides in vaccine design. Nat Rev Drug Discov. 2007, 6 (5): 404-414. 10.1038/nrd2224.CrossRefPubMed
4.
go back to reference Pietersz GA, Pouniotis DS, Apostolopoulos V: Design of peptide-based vaccines for cancer. Curr Med Chem. 2006, 13 (14): 1591-1607. 10.2174/092986706777441922.CrossRefPubMed Pietersz GA, Pouniotis DS, Apostolopoulos V: Design of peptide-based vaccines for cancer. Curr Med Chem. 2006, 13 (14): 1591-1607. 10.2174/092986706777441922.CrossRefPubMed
5.
go back to reference Riedl P, Reimann J, Schirmbeck R: Complexes of DNA vaccines with cationic, antigenic peptides are potent, polyvalent CD8(+) T-cell-stimulating immunogens. Methods in molecular medicine. 2006, 127: 159-169.PubMed Riedl P, Reimann J, Schirmbeck R: Complexes of DNA vaccines with cationic, antigenic peptides are potent, polyvalent CD8(+) T-cell-stimulating immunogens. Methods in molecular medicine. 2006, 127: 159-169.PubMed
6.
go back to reference van der Burg SH, Bijker MS, Welters MJ, Offringa R, Melief CJ: Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy. Advanced drug delivery reviews. 2006, 58 (8): 916-930. 10.1016/j.addr.2005.11.003.CrossRefPubMed van der Burg SH, Bijker MS, Welters MJ, Offringa R, Melief CJ: Improved peptide vaccine strategies, creating synthetic artificial infections to maximize immune efficacy. Advanced drug delivery reviews. 2006, 58 (8): 916-930. 10.1016/j.addr.2005.11.003.CrossRefPubMed
7.
go back to reference Berntsen A, Geertsen PF, Svane IM: Therapeutic dendritic cell vaccination of patients with renal cell carcinoma. European urology. 2006, 50 (1): 34-43. 10.1016/j.eururo.2006.03.061.CrossRefPubMed Berntsen A, Geertsen PF, Svane IM: Therapeutic dendritic cell vaccination of patients with renal cell carcinoma. European urology. 2006, 50 (1): 34-43. 10.1016/j.eururo.2006.03.061.CrossRefPubMed
8.
go back to reference Jiang S, Song R, Popov S, Mirshahidi S, Ruprecht RM: Overlapping synthetic peptides as vaccines. Vaccine. 2006, 24 (37–39): 6356-6365. 10.1016/j.vaccine.2006.04.070.CrossRefPubMed Jiang S, Song R, Popov S, Mirshahidi S, Ruprecht RM: Overlapping synthetic peptides as vaccines. Vaccine. 2006, 24 (37–39): 6356-6365. 10.1016/j.vaccine.2006.04.070.CrossRefPubMed
9.
go back to reference Naz RK, Dabir P: Peptide vaccines against cancer, infectious diseases, and conception. Front Biosci. 2007, 12: 1833-1844. 10.2741/2191.CrossRefPubMed Naz RK, Dabir P: Peptide vaccines against cancer, infectious diseases, and conception. Front Biosci. 2007, 12: 1833-1844. 10.2741/2191.CrossRefPubMed
10.
go back to reference Tumenjargal S, Gellrich S, Linnemann T, Muche JM, Lukowsky A, Audring H, Wiesmuller KH, Sterry W, Walden P: Anti-tumor immune responses and tumor regression induced with mimotopes of a tumor-associated T cell epitope. European journal of immunology. 2003, 33 (11): 3175-3185. 10.1002/eji.200324244.CrossRefPubMed Tumenjargal S, Gellrich S, Linnemann T, Muche JM, Lukowsky A, Audring H, Wiesmuller KH, Sterry W, Walden P: Anti-tumor immune responses and tumor regression induced with mimotopes of a tumor-associated T cell epitope. European journal of immunology. 2003, 33 (11): 3175-3185. 10.1002/eji.200324244.CrossRefPubMed
11.
go back to reference Noguchi M, Itoh K, Suekane S, Yao A, Suetsugu N, Katagiri K, Yamada A, Yamana H, Noda S: Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer. Cancer science. 2004, 95 (1): 77-84. 10.1111/j.1349-7006.2004.tb03174.x.CrossRefPubMed Noguchi M, Itoh K, Suekane S, Yao A, Suetsugu N, Katagiri K, Yamada A, Yamana H, Noda S: Phase I trial of patient-oriented vaccination in HLA-A2-positive patients with metastatic hormone-refractory prostate cancer. Cancer science. 2004, 95 (1): 77-84. 10.1111/j.1349-7006.2004.tb03174.x.CrossRefPubMed
12.
go back to reference Wobser M, Keikavoussi P, Kunzmann V, Weininger M, Andersen MH, Becker JC: Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin. Cancer Immunol Immunother. 2006, 55 (10): 1294-1298. 10.1007/s00262-005-0102-x.CrossRefPubMed Wobser M, Keikavoussi P, Kunzmann V, Weininger M, Andersen MH, Becker JC: Complete remission of liver metastasis of pancreatic cancer under vaccination with a HLA-A2 restricted peptide derived from the universal tumor antigen survivin. Cancer Immunol Immunother. 2006, 55 (10): 1294-1298. 10.1007/s00262-005-0102-x.CrossRefPubMed
13.
go back to reference Bodey B, Bodey B, Siegel SE, Kaiser HE: Failure of cancer vaccines: the significant limitations of this approach to immunotherapy. Anticancer research. 2000, 20 (4): 2665-2676.PubMed Bodey B, Bodey B, Siegel SE, Kaiser HE: Failure of cancer vaccines: the significant limitations of this approach to immunotherapy. Anticancer research. 2000, 20 (4): 2665-2676.PubMed
14.
go back to reference Hersey P, Menzies SW, Halliday GM, Nguyen T, Farrelly ML, DeSilva C, Lett M: Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma. Cancer Immunol Immunother. 2004, 53 (2): 125-134. 10.1007/s00262-003-0429-0.CrossRefPubMed Hersey P, Menzies SW, Halliday GM, Nguyen T, Farrelly ML, DeSilva C, Lett M: Phase I/II study of treatment with dendritic cell vaccines in patients with disseminated melanoma. Cancer Immunol Immunother. 2004, 53 (2): 125-134. 10.1007/s00262-003-0429-0.CrossRefPubMed
15.
go back to reference Sabbatini P, Odunsi K: Immunologic approaches to ovarian cancer treatment. J Clin Oncol. 2007, 25 (20): 2884-2893. 10.1200/JCO.2007.11.0775.CrossRefPubMed Sabbatini P, Odunsi K: Immunologic approaches to ovarian cancer treatment. J Clin Oncol. 2007, 25 (20): 2884-2893. 10.1200/JCO.2007.11.0775.CrossRefPubMed
16.
go back to reference Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, et al.: Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA. 2005, 102 (51): 18538-18543. 10.1073/pnas.0509182102.PubMedCentralCrossRefPubMed Sato E, Olson SH, Ahn J, Bundy B, Nishikawa H, Qian F, Jungbluth AA, Frosina D, Gnjatic S, Ambrosone C, et al.: Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA. 2005, 102 (51): 18538-18543. 10.1073/pnas.0509182102.PubMedCentralCrossRefPubMed
17.
go back to reference Alvaro T, Lejeune M, Salvado MT, Lopez C, Jaen J, Bosch R, Pons LE: Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. J Clin Oncol. 2006, 24 (34): 5350-5357. 10.1200/JCO.2006.06.4766.CrossRefPubMed Alvaro T, Lejeune M, Salvado MT, Lopez C, Jaen J, Bosch R, Pons LE: Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. J Clin Oncol. 2006, 24 (34): 5350-5357. 10.1200/JCO.2006.06.4766.CrossRefPubMed
18.
go back to reference Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, et al.: Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006, 313 (5795): 1960-1964. 10.1126/science.1129139.CrossRefPubMed Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C, Tosolini M, Camus M, Berger A, Wind P, et al.: Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006, 313 (5795): 1960-1964. 10.1126/science.1129139.CrossRefPubMed
19.
go back to reference Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY: Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 2007, 25 (18): 2586-2593. 10.1200/JCO.2006.09.4565.CrossRefPubMed Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY: Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol. 2007, 25 (18): 2586-2593. 10.1200/JCO.2006.09.4565.CrossRefPubMed
20.
go back to reference Muzzi A, Masignani V, Rappuoli R: The pan-genome: towards a knowledge-based discovery of novel targets for vaccines and antibacterials. Drug Discov Today. 2007, 12 (11–12): 429-439. 10.1016/j.drudis.2007.04.008.CrossRefPubMed Muzzi A, Masignani V, Rappuoli R: The pan-genome: towards a knowledge-based discovery of novel targets for vaccines and antibacterials. Drug Discov Today. 2007, 12 (11–12): 429-439. 10.1016/j.drudis.2007.04.008.CrossRefPubMed
21.
go back to reference Van Der Bruggen P, Zhang Y, Chaux P, Stroobant V, Panichelli C, Schultz ES, Chapiro J, Van Den Eynde BJ, Brasseur F, Boon T: Tumor-specific shared antigenic peptides recognized by human T cells. Immunol Rev. 2002, 188: 51-64. 10.1034/j.1600-065X.2002.18806.x.CrossRefPubMed Van Der Bruggen P, Zhang Y, Chaux P, Stroobant V, Panichelli C, Schultz ES, Chapiro J, Van Den Eynde BJ, Brasseur F, Boon T: Tumor-specific shared antigenic peptides recognized by human T cells. Immunol Rev. 2002, 188: 51-64. 10.1034/j.1600-065X.2002.18806.x.CrossRefPubMed
22.
go back to reference Parmiani G, De Filippo A, Novellino L, Castelli C: Unique human tumor antigens: immunobiology and use in clinical trials. J Immunol. 2007, 178 (4): 1975-1979.CrossRefPubMed Parmiani G, De Filippo A, Novellino L, Castelli C: Unique human tumor antigens: immunobiology and use in clinical trials. J Immunol. 2007, 178 (4): 1975-1979.CrossRefPubMed
23.
go back to reference Robinson J, Waller MJ, Fail SC, Marsh SG: The IMGT/HLA and IPD databases. Hum Mutat. 2006, 27 (12): 1192-1199. 10.1002/humu.20406.CrossRefPubMed Robinson J, Waller MJ, Fail SC, Marsh SG: The IMGT/HLA and IPD databases. Hum Mutat. 2006, 27 (12): 1192-1199. 10.1002/humu.20406.CrossRefPubMed
24.
go back to reference Brusic V, Bajic VB, Petrovsky N: Computational methods for prediction of T-cell epitopes – a framework for modelling, testing, and applications. Methods. 2004, 34 (4): 436-443. 10.1016/j.ymeth.2004.06.006.CrossRefPubMed Brusic V, Bajic VB, Petrovsky N: Computational methods for prediction of T-cell epitopes – a framework for modelling, testing, and applications. Methods. 2004, 34 (4): 436-443. 10.1016/j.ymeth.2004.06.006.CrossRefPubMed
26.
go back to reference De Groot AS, Moise L: Prediction of immunogenicity for therapeutic proteins: state of the art. Current opinion in drug discovery & development. 2007, 10 (3): 332-340. De Groot AS, Moise L: Prediction of immunogenicity for therapeutic proteins: state of the art. Current opinion in drug discovery & development. 2007, 10 (3): 332-340.
27.
go back to reference Yu K, Petrovsky N, Schonbach C, Koh JY, Brusic V: Methods for prediction of peptide binding to MHC molecules: a comparative study. Molecular medicine (Cambridge, Mass. 2002, 8 (3): 137-148. Yu K, Petrovsky N, Schonbach C, Koh JY, Brusic V: Methods for prediction of peptide binding to MHC molecules: a comparative study. Molecular medicine (Cambridge, Mass. 2002, 8 (3): 137-148.
28.
go back to reference Peters B, Bui HH, Frankild S, Nielson M, Lundegaard C, Kostem E, Basch D, Lamberth K, Harndahl M, Fleri W, et al.: A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol. 2006, 2 (6): e65-10.1371/journal.pcbi.0020065.PubMedCentralCrossRefPubMed Peters B, Bui HH, Frankild S, Nielson M, Lundegaard C, Kostem E, Basch D, Lamberth K, Harndahl M, Fleri W, et al.: A community resource benchmarking predictions of peptide binding to MHC-I molecules. PLoS Comput Biol. 2006, 2 (6): e65-10.1371/journal.pcbi.0020065.PubMedCentralCrossRefPubMed
29.
go back to reference Trost B, Bickis M, Kusalik A: Strength in numbers: achieving greater accuracy in MHC-I binding prediction by combining the results from multiple prediction tools. Immunome Res. 2007, 3 (1): 5-10.1186/1745-7580-3-5.PubMedCentralCrossRefPubMed Trost B, Bickis M, Kusalik A: Strength in numbers: achieving greater accuracy in MHC-I binding prediction by combining the results from multiple prediction tools. Immunome Res. 2007, 3 (1): 5-10.1186/1745-7580-3-5.PubMedCentralCrossRefPubMed
30.
go back to reference Pasquetto V, Bui HH, Giannino R, Banh C, Mirza F, Sidney J, Oseroff C, Tscharke DC, Irvine K, Bennink JR, et al.: HLA-A* HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. J Immunol. 2005, 175 (8): 5504-5515.CrossRefPubMed Pasquetto V, Bui HH, Giannino R, Banh C, Mirza F, Sidney J, Oseroff C, Tscharke DC, Irvine K, Bennink JR, et al.: HLA-A* HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products. J Immunol. 2005, 175 (8): 5504-5515.CrossRefPubMed
31.
go back to reference Lundegaard C, Lund O, Kesmir C, Brunak S, Nielsen M: Modeling the adaptive immune system: predictions and simulations. Bioinformatics. 2007, 23 (24): 3265-3275. 10.1093/bioinformatics/btm471.CrossRefPubMed Lundegaard C, Lund O, Kesmir C, Brunak S, Nielsen M: Modeling the adaptive immune system: predictions and simulations. Bioinformatics. 2007, 23 (24): 3265-3275. 10.1093/bioinformatics/btm471.CrossRefPubMed
32.
go back to reference Peters B: Modeling the MHC-I pathway. PhD In Thesis (PhD). 2003, Berlin, Germany, Humboldt University Peters B: Modeling the MHC-I pathway. PhD In Thesis (PhD). 2003, Berlin, Germany, Humboldt University
33.
go back to reference Tiwari N, Garbi N, Reinheckel T, Moldenhauer G, Hämmerling GJ, Momburg F: A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins. J Immunol. 2007, 178 (12): 7932-7942.CrossRefPubMed Tiwari N, Garbi N, Reinheckel T, Moldenhauer G, Hämmerling GJ, Momburg F: A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins. J Immunol. 2007, 178 (12): 7932-7942.CrossRefPubMed
34.
go back to reference Demirel O, Waibler Z, Kalinke U, Grünebach F, Appel S, Brossart P, Hasilik A, Tampé R, Abele R: Identification of a lysosomal peptide transport system induced during dendritic cell development. J Biol Chem. 2007, 282 (52): 37836-37843. 10.1074/jbc.M708139200.CrossRefPubMed Demirel O, Waibler Z, Kalinke U, Grünebach F, Appel S, Brossart P, Hasilik A, Tampé R, Abele R: Identification of a lysosomal peptide transport system induced during dendritic cell development. J Biol Chem. 2007, 282 (52): 37836-37843. 10.1074/jbc.M708139200.CrossRefPubMed
35.
go back to reference Kurotaki T, Tamura Y, Ueda G, Oura J, Kutomi G, Hirohashi Y, Sahara H, Torigoe T, Hiratsuka H, Sunakawa H, Hirata K, Sato N: Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway. J Immunol. 2007, 179 (3): 1803-1813.CrossRefPubMed Kurotaki T, Tamura Y, Ueda G, Oura J, Kutomi G, Hirohashi Y, Sahara H, Torigoe T, Hiratsuka H, Sunakawa H, Hirata K, Sato N: Efficient cross-presentation by heat shock protein 90-peptide complex-loaded dendritic cells via an endosomal pathway. J Immunol. 2007, 179 (3): 1803-1813.CrossRefPubMed
36.
go back to reference Franco A, Tilly DA, Gramaglia I, Croft M, Cipolla L, Meldal M, Grey HM: Epitope affinity for MHC class I determines helper requirement for CTL priming. Nat Immunol. 2000, 1 (2): 145-150. 10.1038/77827.CrossRefPubMed Franco A, Tilly DA, Gramaglia I, Croft M, Cipolla L, Meldal M, Grey HM: Epitope affinity for MHC class I determines helper requirement for CTL priming. Nat Immunol. 2000, 1 (2): 145-150. 10.1038/77827.CrossRefPubMed
37.
go back to reference Louzoun Y, Vider T, Weigert M: T-cell epitope repertoire as predicted from human and viral genomes. Mol Immunol. 2006, 43 (6): 559-569. 10.1016/j.molimm.2005.04.017.CrossRefPubMed Louzoun Y, Vider T, Weigert M: T-cell epitope repertoire as predicted from human and viral genomes. Mol Immunol. 2006, 43 (6): 559-569. 10.1016/j.molimm.2005.04.017.CrossRefPubMed
38.
go back to reference Petrovsky N, Brusic V: Computational immunology: The coming of age. Immunology and cell biology. 2002, 80 (3): 248-254. 10.1046/j.1440-1711.2002.01093.x.CrossRefPubMed Petrovsky N, Brusic V: Computational immunology: The coming of age. Immunology and cell biology. 2002, 80 (3): 248-254. 10.1046/j.1440-1711.2002.01093.x.CrossRefPubMed
39.
go back to reference Parker KC, Bednarek MA, Coligan JE: Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol. 1994, 152 (1): 163-175.PubMed Parker KC, Bednarek MA, Coligan JE: Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol. 1994, 152 (1): 163-175.PubMed
40.
go back to reference Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S: SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics. 1999, 50 (3–4): 213-219. 10.1007/s002510050595.CrossRefPubMed Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S: SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics. 1999, 50 (3–4): 213-219. 10.1007/s002510050595.CrossRefPubMed
41.
go back to reference Reche PA, Glutting JP, Reinherz EL: Prediction of MHC class I binding peptides using profile motifs. Hum Immunol. 2002, 63 (9): 701-709. 10.1016/S0198-8859(02)00432-9.CrossRefPubMed Reche PA, Glutting JP, Reinherz EL: Prediction of MHC class I binding peptides using profile motifs. Hum Immunol. 2002, 63 (9): 701-709. 10.1016/S0198-8859(02)00432-9.CrossRefPubMed
42.
go back to reference Singh H, Raghava GP: ProPred1: prediction of promiscuous MHC Class-I binding sites. Bioinformatics. 2003, 19 (8): 1009-1014. 10.1093/bioinformatics/btg108.CrossRefPubMed Singh H, Raghava GP: ProPred1: prediction of promiscuous MHC Class-I binding sites. Bioinformatics. 2003, 19 (8): 1009-1014. 10.1093/bioinformatics/btg108.CrossRefPubMed
43.
go back to reference Hakenberg J, Nussbaum AK, Schild H, Rammensee HG, Kuttler C, Holzhutter HG, Kloetzel PM, Kaufmann SH, Mollenkopf HJ: MAPPP: MHC class I antigenic peptide processing prediction. Appl Bioinformatics. 2003, 2 (3): 155-158.PubMed Hakenberg J, Nussbaum AK, Schild H, Rammensee HG, Kuttler C, Holzhutter HG, Kloetzel PM, Kaufmann SH, Mollenkopf HJ: MAPPP: MHC class I antigenic peptide processing prediction. Appl Bioinformatics. 2003, 2 (3): 155-158.PubMed
44.
go back to reference Nielsen M, Lundegaard C, Worning P, Hvid CS, Lamberth K, Buus S, Brunak S, Lund O: Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics. 2004, 20 (9): 1388-1397. 10.1093/bioinformatics/bth100.CrossRefPubMed Nielsen M, Lundegaard C, Worning P, Hvid CS, Lamberth K, Buus S, Brunak S, Lund O: Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics. 2004, 20 (9): 1388-1397. 10.1093/bioinformatics/bth100.CrossRefPubMed
45.
go back to reference Peters B, Sidney J, Bourne P, Bui HH, Buus S, Doh G, Fleri W, Kronenberg M, Kubo R, Lund O, et al.: The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol. 2005, 3 (3): e91-10.1371/journal.pbio.0030091.PubMedCentralCrossRefPubMed Peters B, Sidney J, Bourne P, Bui HH, Buus S, Doh G, Fleri W, Kronenberg M, Kubo R, Lund O, et al.: The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol. 2005, 3 (3): e91-10.1371/journal.pbio.0030091.PubMedCentralCrossRefPubMed
46.
go back to reference DeLuca DS, Khattab B, Blasczyk R: A modular concept of HLA for comprehensive peptide binding prediction. Immunogenetics. 2007, 59 (1): 25-35. 10.1007/s00251-006-0176-4.CrossRefPubMed DeLuca DS, Khattab B, Blasczyk R: A modular concept of HLA for comprehensive peptide binding prediction. Immunogenetics. 2007, 59 (1): 25-35. 10.1007/s00251-006-0176-4.CrossRefPubMed
47.
go back to reference Sathiamurthy M, Hickman HD, Cavett JW, Zahoor A, Prilliman K, Metcalf S, Fernandez Vina M, Hildebrand WH: Population of the HLA ligand database. Tissue Antigens. 2003, 61 (1): 12-19. 10.1034/j.1399-0039.2003.610102.x.CrossRefPubMed Sathiamurthy M, Hickman HD, Cavett JW, Zahoor A, Prilliman K, Metcalf S, Fernandez Vina M, Hildebrand WH: Population of the HLA ligand database. Tissue Antigens. 2003, 61 (1): 12-19. 10.1034/j.1399-0039.2003.610102.x.CrossRefPubMed
48.
go back to reference Bui HH, Sidney J, Peters B, Sathiamurthy M, Sinichi A, Purton KA, Mothe BR, Chisari FV, Watkins DI, Sette A: Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics. 2005, 57 (5): 304-314. 10.1007/s00251-005-0798-y.CrossRefPubMed Bui HH, Sidney J, Peters B, Sathiamurthy M, Sinichi A, Purton KA, Mothe BR, Chisari FV, Watkins DI, Sette A: Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics. 2005, 57 (5): 304-314. 10.1007/s00251-005-0798-y.CrossRefPubMed
49.
go back to reference Peters B, Sette A: Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics. 2005, 6: 132-10.1186/1471-2105-6-132.PubMedCentralCrossRefPubMed Peters B, Sette A: Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method. BMC Bioinformatics. 2005, 6: 132-10.1186/1471-2105-6-132.PubMedCentralCrossRefPubMed
50.
go back to reference Peters B, Tong W, Sidney J, Sette A, Weng Z: Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules. Bioinformatics. 2003, 19 (14): 1765-1772. 10.1093/bioinformatics/btg247.CrossRefPubMed Peters B, Tong W, Sidney J, Sette A, Weng Z: Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules. Bioinformatics. 2003, 19 (14): 1765-1772. 10.1093/bioinformatics/btg247.CrossRefPubMed
51.
go back to reference Buus S, Lauemoller SL, Worning P, Kesmir C, Frimurer T, Corbet S, Fomsgaard A, Hilden J, Holm A, Brunak S: Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens. 2003, 62 (5): 378-384. 10.1034/j.1399-0039.2003.00112.x.CrossRefPubMed Buus S, Lauemoller SL, Worning P, Kesmir C, Frimurer T, Corbet S, Fomsgaard A, Hilden J, Holm A, Brunak S: Sensitive quantitative predictions of peptide-MHC binding by a 'Query by Committee' artificial neural network approach. Tissue Antigens. 2003, 62 (5): 378-384. 10.1034/j.1399-0039.2003.00112.x.CrossRefPubMed
52.
go back to reference Zhang GL, Khan AM, Srinivasan KN, August JT, Brusic V: MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides. Nucleic Acids Res. 2005, W172-179. 10.1093/nar/gki452. 33 Web Server Zhang GL, Khan AM, Srinivasan KN, August JT, Brusic V: MULTIPRED: a computational system for prediction of promiscuous HLA binding peptides. Nucleic Acids Res. 2005, W172-179. 10.1093/nar/gki452. 33 Web Server
53.
go back to reference Bhasin M, Raghava GP: A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes. J Biosci. 2007, 32 (1): 31-42. 10.1007/s12038-007-0004-5.CrossRefPubMed Bhasin M, Raghava GP: A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes. J Biosci. 2007, 32 (1): 31-42. 10.1007/s12038-007-0004-5.CrossRefPubMed
54.
go back to reference Nielsen M, Lundegaard C, Worning P, Lauemoller SL, Lamberth K, Buus S, Brunak S, Lund O: Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci. 2003, 12 (5): 1007-1017. 10.1110/ps.0239403.PubMedCentralCrossRefPubMed Nielsen M, Lundegaard C, Worning P, Lauemoller SL, Lamberth K, Buus S, Brunak S, Lund O: Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci. 2003, 12 (5): 1007-1017. 10.1110/ps.0239403.PubMedCentralCrossRefPubMed
55.
go back to reference Cui J, Han LY, Lin HH, Tang ZQ, Jiang L, Cao ZW, Chen YZ: MHC-BPS: MHC-binder prediction server for identifying peptides of flexible lengths from sequence-derived physicochemical properties. Immunogenetics. 2006, 58 (8): 607-613. 10.1007/s00251-006-0117-2.CrossRefPubMed Cui J, Han LY, Lin HH, Tang ZQ, Jiang L, Cao ZW, Chen YZ: MHC-BPS: MHC-binder prediction server for identifying peptides of flexible lengths from sequence-derived physicochemical properties. Immunogenetics. 2006, 58 (8): 607-613. 10.1007/s00251-006-0117-2.CrossRefPubMed
56.
go back to reference Donnes P, Kohlbacher O: SVMHC: a server for prediction of MHC-binding peptides. Nucleic Acids Res. 2006, W194-197. 10.1093/nar/gkl284. 34 Web Server Donnes P, Kohlbacher O: SVMHC: a server for prediction of MHC-binding peptides. Nucleic Acids Res. 2006, W194-197. 10.1093/nar/gkl284. 34 Web Server
57.
go back to reference Wan J, Liu W, Xu Q, Ren Y, Flower DR, Li T: SVRMHC prediction server for MHC-binding peptides. BMC Bioinformatics. 2006, 7: 463-10.1186/1471-2105-7-463.PubMedCentralCrossRefPubMed Wan J, Liu W, Xu Q, Ren Y, Flower DR, Li T: SVRMHC prediction server for MHC-binding peptides. BMC Bioinformatics. 2006, 7: 463-10.1186/1471-2105-7-463.PubMedCentralCrossRefPubMed
58.
go back to reference Zhang GL, Bozic I, Kwoh CK, August JT, Brusic V: Prediction of supertype-specific HLA class I binding peptides using support vector machines. J Immunol Methods. 2007, 320 (1–2): 143-154. 10.1016/j.jim.2006.12.011.PubMedCentralCrossRefPubMed Zhang GL, Bozic I, Kwoh CK, August JT, Brusic V: Prediction of supertype-specific HLA class I binding peptides using support vector machines. J Immunol Methods. 2007, 320 (1–2): 143-154. 10.1016/j.jim.2006.12.011.PubMedCentralCrossRefPubMed
59.
go back to reference Schueler-Furman O, Altuvia Y, Sette A, Margalit H: Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles. Protein Sci. 2000, 9 (9): 1838-1846.PubMedCentralCrossRefPubMed Schueler-Furman O, Altuvia Y, Sette A, Margalit H: Structure-based prediction of binding peptides to MHC class I molecules: application to a broad range of MHC alleles. Protein Sci. 2000, 9 (9): 1838-1846.PubMedCentralCrossRefPubMed
60.
go back to reference Jojic N, Reyes-Gomez M, Heckerman D, Kadie C, Schueler-Furman O: Learning MHC I – peptide binding. Bioinformatics. 2006, 22 (14): e227-235. 10.1093/bioinformatics/btl255.CrossRefPubMed Jojic N, Reyes-Gomez M, Heckerman D, Kadie C, Schueler-Furman O: Learning MHC I – peptide binding. Bioinformatics. 2006, 22 (14): e227-235. 10.1093/bioinformatics/btl255.CrossRefPubMed
61.
go back to reference Guan P, Hattotuwagama CK, Doytchinova IA, Flower DR: MHCPred 2.0: an updated quantitative T-cell epitope prediction server. Appl Bioinformatics. 2006, 5 (1): 55-61. 10.2165/00822942-200605010-00008.CrossRefPubMed Guan P, Hattotuwagama CK, Doytchinova IA, Flower DR: MHCPred 2.0: an updated quantitative T-cell epitope prediction server. Appl Bioinformatics. 2006, 5 (1): 55-61. 10.2165/00822942-200605010-00008.CrossRefPubMed
62.
go back to reference Hertz T, Yanover C: PepDist: a new framework for protein-peptide binding prediction based on learning peptide distance functions. BMC Bioinformatics. 2006, 7 (Suppl 1): S3-10.1186/1471-2105-7-S1-S3.PubMedCentralCrossRefPubMed Hertz T, Yanover C: PepDist: a new framework for protein-peptide binding prediction based on learning peptide distance functions. BMC Bioinformatics. 2006, 7 (Suppl 1): S3-10.1186/1471-2105-7-S1-S3.PubMedCentralCrossRefPubMed
63.
go back to reference Bachinsky MM, Guillen DE, Patel SR, Singleton J, Chen C, Soltis DA, Tussey LG: Mapping and binding analysis of peptides derived from the tumor-associated antigen survivin for eight HLA alleles. Cancer Immun. 2005, 5: 6-PubMed Bachinsky MM, Guillen DE, Patel SR, Singleton J, Chen C, Soltis DA, Tussey LG: Mapping and binding analysis of peptides derived from the tumor-associated antigen survivin for eight HLA alleles. Cancer Immun. 2005, 5: 6-PubMed
64.
go back to reference Movassagh M, Monseaux S, Arnaud L, Necker A, Montero-Julian FA: Identification of T cell epitopes by iTopia™ epitope discovery system. Cytometry A. 2004, 59A (1): 32- Movassagh M, Monseaux S, Arnaud L, Necker A, Montero-Julian FA: Identification of T cell epitopes by iTopia™ epitope discovery system. Cytometry A. 2004, 59A (1): 32-
66.
go back to reference Swets JA: Measuring the accuracy of diagnostic systems. Science. 1988, 240: 1285-1293. 10.1126/science.3287615.CrossRefPubMed Swets JA: Measuring the accuracy of diagnostic systems. Science. 1988, 240: 1285-1293. 10.1126/science.3287615.CrossRefPubMed
67.
go back to reference Box GE, Cox DR: An analysis of transformations. J R Stat Soc [Ser B]. 1964, 26: 211-246. Box GE, Cox DR: An analysis of transformations. J R Stat Soc [Ser B]. 1964, 26: 211-246.
Metadata
Title
Evaluation of MHC class I peptide binding prediction servers: Applications for vaccine research
Authors
Hong Huang Lin
Surajit Ray
Songsak Tongchusak
Ellis L Reinherz
Vladimir Brusic
Publication date
01-12-2008
Publisher
BioMed Central
Published in
BMC Immunology / Issue 1/2008
Electronic ISSN: 1471-2172
DOI
https://doi.org/10.1186/1471-2172-9-8

Other articles of this Issue 1/2008

BMC Immunology 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine